(1) The pharmacist-in-charge shall ensure that medications are timely delivered so that the prescription for sterile pharmaceuticals can be implemented without undue delay. Once therapy has been initiated, the pharmacy shall continue to provide sterile pharmaceuticals in a timely fashion so as not to interrupt ongoing therapy.
(2) The pharmacist-in-charge shall ensure the environmental control of all products shipped. All compounded, sterile pharmaceuticals must be shipped or delivered, other than those compounded in an institutional setting, to a patient in appropriate, temperature-controlled (as defined by the United States Pharmacopeia/National Formulary) delivery containers and stored appropriately in the patient's therapy setting.
(3) Patients must be notified in advance of delivery of the products. Patients must be provided with a receipt for all sterile products and supplies delivered to them.
(4) The pharmacy shall document a chain of possession for all controlled substances.